| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CEA cell adhesion molecule 5 | ||||
| GTO ID | GTC1978 |
| Trial ID | NCT03682744 |
| Disease | Peritoneal Carcinoma | Breast Cancer | Pancreas Cancer | Colorectal Cancer | Stomach Cancer |
| Altered gene | CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CEA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Withdrawn |
| Title | CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC) |
| Year | 2018 |
| Country | United States |
| Company sponsor | Sorrento Therapeutics, Inc. |
| Other ID(s) | 340-74 |
| Cohort 1 | |||||||
|
|||||||